Microfluidics Market by Application (Genomics, Proteomics, Capillary Electrophoresis, IVD (POC, Clinical Diagnostics), Drug Delivery, Microreactor, Lab Tests), Component (Chips, Pump, Needle), Material (Polymer, Glass, Silicon) - Global Forecast to 2023
Get in-depth analysis of how COVID-19 is impacting the Microfluidics Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Microfluidics Market
Request Now[228 Pages Report] MarketsandMarkets forecasts the Microfluidics market to grow from USD 10.06 billion in 2018 to USD 27.91 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 22.6% during the forecast period. Microfluidic technologies offer quick analysis, reduced reagent consumption, and accurate test results, and help in reducing the overall cost of the drug development process. In the market, there is a growing demand for POC diagnostic devices, such as glucose monitoring and pregnancy test kits, which is expected to further drive the demand for microfluidics.
However, there are certain challenges such as a lack of market visibility of microfluidics products, high prices of integrated systems and microfluidics sensors, and the complex & time-consuming regulatory approval process, which restrain the growth of this market. The growing Asian market and the expanding applications of drug delivery technologies are expected to provide further growth opportunities for players operating in this market.
In vitro diagnostics application segment is expected to register the highest CAGR during the forecast period.
On the basis of application, the Microfluidics market is segmented into in vitro diagnostics (IVD) segment pharmaceutical and life science research, drug delivery, laboratory testing, and high throughput screening. The IVD segment is expected to register the highest CAGR during the forecast period. The growth of this segment is mainly attributed to the rising incidences of target diseases and conditions and demand for POC testing. In addition, the advantages of microfluidic devices over traditional counterparts, such as portability, reduced size of the device, increased frequency of testing, and accurate & quick analysis, have driven their adoption in this application segment.
Microfluidic sensors segment is expected to grow at the highest CAGR during 2018 to 2023.
On the basis of type, the microfluidic components market is segmented into microfluidic chips, microfluidic pumps, microfluidics sensors, microneedles, and other components (microfluidic valves, connectors, tubes, temperature controllers, OEM components, and high-pressure fluid processors, among other components). In 2017, the microfluidic sensors segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the utilization of microfluidic sensors in several types of diagnostic and research products.
APAC is projected to witness the highest growth during the forecast period.
North America held the largest share of the global Microfluidics market in 2017. On the other hand, the Asia-Pacific region is expected to witness the highest CAGR during the forecast period. This growth can be attributed to the rising geriatric population, growing per capita income, increasing investments in the healthcare industry, rising demand for advanced technologies, and expansion of private-sector hospitals to rural areas in various countries in the region.
North America to account for the largest market size during the forecast period.
North America is the largest market for Microfluidics, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The overall growth of the microfluidics market in North America is primarily driven by the growing incidence rate of chronic diseases, availability of insurance coverage for laboratory testing procedures, sufficient reimbursements for medical devices, and presence of well-structured distribution channels in the region. In addition, an increase in the demand for self-administration and home healthcare devices, and increasing applications of micropumps, inhalers, and transdermal microneedles for chronic conditions such as migraine, diabetes, cancer pain, and asthma have boosted the growth of this market.
Market Dynamics
Driver: Rising demand for point-of-care testing
The global POC diagnostics market is expected to showcase a lucrative growth potential (~10%) in the coming years. This is mainly due to the rising prevalence of lifestyle-related & infectious diseases and increasing preference for home healthcare. In addition, the growing private investments and venture funding for the development of new products, coupled with government support for improving the adoption of POC devices, are supporting the growth of the POC diagnostics market.
The rising incidence and prevalence of various diseases, coupled with product miniaturization and decentralization of healthcare, are the major factors that are expected to offer significant growth opportunities to players operating in the POC diagnostics market. Cancer is a major health concern in modern societies and the second-leading cause of death for geriatrics, globally. According to the National Cancer Institute, the cost of cancer treatment in the US was USD 125 billion in 2010 and is expected to reach USD 158 billion by 2020. According to the World Cancer Research Fund International (WCRFI), in 2012, there were an estimated 14.1 million new cancer cases worldwide; this figure increased to 17.5 million in 2015 and is expected to reach 24 million by 2035. The rising incidence of cancer is expected to increase the uptake of cancer-related diagnostic technologies. The increasing incidence of other major chronic and infectious diseases, coupled with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new avenues for the growth of the POC diagnostics market. This, in turn, is expected to support the growth of the microfluidics market as POC testing is the largest segment of the microfluidics market for in vitro diagnostics.
Restraint: Complex and time-consuming regulatory approval process
Manufacturers of medical devices are required to comply with stringent regulatory policies to ensure the marketing and sales of their products in global markets. The US is a major manufacturing hub for microfluidic devices as a majority of the leading global players are based in the country. In the US, the FDA has set stringent regulatory standards and guidelines to ensure the safety and efficacy of medical devices. However, over the last few years, the FDA approval process for medical devices has become a lengthy and complex process. This is a major challenge faced by companies while launching new and innovative products in the US. For instance, the average approval time for a 510(K) application increased to 151 days during 2011-15, which was 96 days from 2001-05. This is expected to have a major impact on the drug delivery, pharmaceutical, and IVD industries. Furthermore, during the approval process, it is not certain whether the product will receive approval, or the terms of approval may have a negative impact on the profitability of the product. Any enforcement action by governments also results in negative publicity, which impacts the market adversely.
Several innovative microfluidic devices are currently under development, while a few have already been launched in the market. As microfluidics is a relatively emerging technology and a significant amount of study is yet to be carried out on the technology, its potential effects on human health and safety remain unclear. Owing to this, it is necessary that the safety aspects of microfluidic devices are properly and systematically addressed. In this regard, manufacturers need to analyze their devices for various risks and provide appropriate and latest scientific data of the technology used in the device. In the case of innovative microfluidic devices, sufficient scientific data is still not available. Thus, regulatory authorities in different countries need to formulate a standard framework for the safety assessment of microfluidics products. This would reduce the health and safety risks and improve the acceptance of these products in the market.
Opportunity: Asia as a key growth hotspot
Asia is expected to provide significant growth opportunities for players operating in the microfluidics market. Healthcare organizations in several Asian countries are focusing on curbing the rising prevalence of severe diseases and establishing new healthcare delivery models to serve larger sections of the population. Moreover, governments in several Asian countries are encouraging private investments in their respective healthcare sectors and are actively involved in developing public-private partnerships to improve access to healthcare services. For instance, in China, the private hospital sector is expected to maintain double-digit growth over the coming years, owing to regulatory changes, increasing market demand, and growing capital investments. In the private hospitals sector, specialty hospitals are leading market growth. According to the National Health and Family Planning Commission (NHFPC), the number of private hospitals in China has increased from 5,400 in 2008 to 10,877 in 2014 and 16,900 in 2017. Public & private equity firms and venture capitalists are increasingly investing in countries such as India, China, and Japan.
The availability of funds for research is also a key contributor towards Asias growth potential. For instance, the Indian government allocated a budget of about USD 268 million for biotechnology research for FY 2016-17, which is a 12% increase over the previous year. In Japan, the Global Health Innovative Technology Fund (GHIT Fund), which is a public-private partnership, is dedicated towards Japanese R&D focusing on research related to infectious diseases. It offers funds to various partnerships between Japanese and non-Japanese organizations, which include various pharmaceutical companies, academic and research institutions, and product development partnerships (PDPs). These partnerships are involved in conducting R&D, including screening of compound libraries related to various infectious diseases. The cost incurred in these R&D activities is reimbursed by the GHIT Fund. For instance, in October 2016, the GHIT granted USD 11.4 million to six global partnerships for supporting R&D activities on infectious diseases such as tuberculosis, malaria, and dengue.
Growing investments, favorable regulatory policies, and growth in healthcare and biotechnology industries in emerging Asian markets are expected to provide potential growth opportunities for players operating in the microfluidics market.
Challenge: Standardization/commercialization of microfluidic devices
Customer acceptance and market adoption are the two major factors that affect the commercialization of any product or technology in the market. There are many academic publications of proof-of-concept for microfluidic technology-embedded medical devices and equipment, but the incorporation of this technology in end-use products has been limited over the last decade owing to the lack of standardized microfluidic devices that can be used by multiple end users.
Despite the fact that microfluidics is a promising laboratory tool and is used in some applications, the technology is still not widely adopted in major applications in the life sciences and medical device industries. In addition, investors and venture capitalists are more interested in investing their funds in projects or products that give them faster returns on investment. As a result, researchers are forced to redirect their focus from innovative technologies such as microfluidics to other marketable products.
In order to overcome the barriers related to the commercialization of the microfluidics technology, major players in the market need to focus on standardization and the integration of this technology in medical devices and research equipment.
Scope of the Report
|
Report Metric |
Details |
|
Market size available for years |
20162023 |
|
Base year considered |
2017 |
|
Forecast period |
20182023 |
|
Forecast units |
Million (USD) |
|
Segments covered |
|
|
Geographies covered |
North America, Europe, APAC, Latin America, and MEA |
|
Companies covered |
Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Illumina (US), F. Hoffmann-La Roche (Switzerland), Fluidigm Corporation (US), Dolomite Microfluidics (UK), QIAGEN (Netherlands), Abbott Laboartories (US), bioMιrieux (France), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), and Micronit Microtechnologies (Netherlands). |
The research report categorizes the Microfluidics market to forecast the revenues and analyze the trends in each of the following sub-segments:
Microfluidics Market, by Application
- In vitro diagnostics
- Point-of-care Testing
- Clinical Diagnostics
- Pharmaceutical research
- Lab analytics
- Proteomic Analysis
- Genomic Analysis
- Cell-based Assay
- Capillary Electrophoresis
- Micropispensing
- Microreaction
- Drug Delivery
- Laboratory Testing
- Agro food Testing
- Industrial Testing
- Environmental Testing
- High Throughput Screening
Microfluidic Components Market, by Type
- Microfluidic Chips
- Microfluidic Sensors
- Microfluidic Pumps
- Microneedles
- Other Component (Flow Controller, Temperature controller, connectors, droplet generator, microreactors, and valves)
Microfluidic Components Market, by Material
- Polymer-based Microfluidics
- Glass-based Microfluidics
- Silicone-based Microfluidics
- Other material-based Microfluidics (Paper, Ceramics, & Metal)
Microfluidics Market, by Region
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
Key Market Players
Danaher Corporation (US) Thermo Fisher Scientific (US), PerkinElmer (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Illumina (US), F. Hoffmann-La Roche (Switzerland), Fluidigm Corporation (US), Dolomite Microfluidics (UK), QIAGEN (Netherlands), Abbott Laboartories (US), bioMιrieux (France), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), and Micronit Microtechnologies (Netherlands).
The global microfluidics market was dominated by four major players. The microfluidics market is fragmented and competitive. Dominant market players have numerous advantages such as greater budgets for R&D, capabilities to sustain a comparatively longer payback period, stronger marketing & distribution networks, and brand recognition. Competing factors include are costs, sensitivity, safety, innovation, and technical support. The global microfluidics market is primarily dominated by Danaher Corporation (US), Thermo Fisher Scientific (US), PerkinElmer (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), Illumina (US), F. Hoffmann-La Roche (Switzerland), Fluidigm Corporation (US), Dolomite Microfluidics (UK), and QIAGEN (Netherlands).
Danaher is a science and technology innovator, with a global family of more than 20 operating sub-companies. Of all the companies under the Danaher Corporation, Cepheid (US) Beckman Coulter, Inc. (US), AB Sciex LLC (US) and Molecular Devices, LLC (US) are currently employed in providing solutions, among others, for the microfluidics market. The company has strategically enhanced its presence in the global microfluidics market by pursuing a number of inorganic and organic growth strategies such as acquisitions. For instance, in November 2016, the company acquired Cepheid Inc. (US), a leading and innovative global molecular diagnostics company, thus strengthening Danahers portfolio with its GeneXpert systems. Danaher Corporation has facilities in over 60 countries, which include 336 significant manufacturing and distribution facilities; 160 of the total facilities are located in the US in over 25 states and 176 are located outside the US in over 30 other countries primarily in Europe and to a lesser extent in Asia, and the rest of North America, South America, and Australia.
Recent Developments
- In 2016, Danaher acquired Cepheid (US). This acquisition provided Danaher with Cepheids GeneXpert systems, which enable rapid and sophisticated genetic testing. This acquisition expanded Danahers USD 5 billion diagnostic segment.
- In 2015, Danaher acquired Sutron (US). The acquisition expanded the product portfolio of the company for microfluidics sensors used in microfluidics.
Critical questions the report answers:
- Where will all these developments take the industry in the long term?
- What are the upcoming trends for the Microfluidics market?
- Which segment provides the most opportunity for growth?
- Who are the leading vendors operating in this market?
- What are the opportunities for new market entrants?
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction
1.1 Objectives of the Study
1.2 Definition
1.3 Scope of the Study
1.3.1 Markets Covered
1.4 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Growth Potential of the Microfluidics Market
4.2 Asia Pacific Microfluidic Components Market, By Material
4.3 Geographic Growth Opportunities
4.4 By Geography
4.5 Developing vs Developed Countries
5 Market Overview
5.1 Introduction
5.2 microfluidics Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Demand for Point-Of-Care Testing
5.2.1.2 Fast Returns on Investment
5.2.1.3 Faster Testing and Improved Portability Through Microfluidic Chip Miniaturization
5.2.1.4 Entry of New Players and Launch of New and Advanced Products
5.2.2 Restraints
5.2.2.1 Complex and Time-Consuming Regulatory Approval Process
5.2.2.2 Incorporation of Microfluidics Technology Into Existing Workflows
5.2.3 Opportunities
5.2.3.1 Asia as A Key Growth Hotspot
5.2.3.2 Expanding Applications of Drug Delivery Technologies
5.2.3.3 Growing Applications of Microfluidics Technology
5.2.4 Challenge
5.2.4.1 Standardization/Commercialization of Microfluidic Devices
6 Industry Insights
6.1 Introduction
6.2 Industry Trends
6.2.1 Shifting Trend Toward the Adoption of Polymers
6.2.2 Universities Actively Generating Microfluidic Startups and Large Players Acquiring Small Players
6.3 Parent Markets Analysis
6.4 Evolution of Microfluidics Technology in Healthcare
6.5 Value Chain Analysis
6.5.1 Microfluidic Components Procurement Model of Major Players
7 Microfluidics Market, By Application
7.1 Introduction
7.2 in Vitro Diagnostics
7.2.1 Point-Of-Care Testing
7.2.2 Clinical Diagnostics
7.3 Pharmaceutical and Life Science Research
7.3.1 Lab Analytics
7.3.1.1 Proteomic Analysis
7.3.1.2 Genomic Analysis
7.3.1.3 Cell-Based Assays
7.3.1.4 Capillary Electrophoresis
7.3.2 Microdispensing
7.3.3 Microreaction
7.4 Drug Delivery
7.5 Laboratory Testing
7.5.1 Agro Food Testing
7.5.2 Industrial Testing
7.5.3 Environmental Testing
7.6 High Throughput Screening
8 Microfluidic Components Market
8.1 Microfluidic Components Market, By Type
8.1.1 Microfluidic Chips
8.1.2 Microfluidic Sensors
8.1.3 Micropumps
8.1.4 Microneedles
8.1.5 Other Components
8.2 Microfluidic Components Market, By Material
8.2.1 Polymer
8.2.2 Glass
8.2.3 Silicon
8.2.4 Other Materials
9 By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape
10.1 Overview
10.2 Product Portfolio Matrix
10.3 Competitive Situations and Trends
10.3.1 Product Launches
10.3.2 Partnerships, Agreements, and Collaborations
10.3.3 Acquisitions
10.3.4 Expansions
11 Company Profiles
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Danaher Corporation
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 Recent Developments
11.1.4 SWOT Analysis
11.1.5 MnM View
11.2 Thermo Fisher Scientific
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 SWOT Analysis
11.2.5 MnM View
11.3 Perkinelmer
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 SWOT Analysis
11.3.5 MnM View
11.4 Agilent Technologies
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.4.4 SWOT Analysis
11.4.5 MnM View
11.5 Bio-Rad Laboratories
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.5.4 SWOT Analysis
11.5.5 MnM View
11.6 Becton, Dickinson And Company
11.6.1 Business Overview
11.6.2 Products Offered
11.6.3 Recent Developments
11.6.4 MnM View
11.7 Illumina
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.8 F. Hoffmann-La Roche
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.8.4 MnM View
11.9 Fluidigm Corporation
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.9.4 MnM View
11.1 Dolomite Microfluidics
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.10.4 MnM View
11.11 Qiagen
11.11.1 Business Overview
11.11.2 Products Offered
11.11.3 Recent Developments
11.11.4 MnM View
11.12 Abbott Laboratories
11.12.1 Business Overview
11.12.2 Products Offered
11.12.3 Recent Developments
11.12.4 MnM View
11.13 Biomιrieux
11.13.1 Business Overview
11.13.2 Products Offered
11.13.3 Recent Developments
11.13.4 MnM View
11.14 Microfluidic Chipshop
11.14.1 Business Overview
11.14.2 Products Offered
11.15 Elveflow
11.15.1 Business Overview
11.15.2 Products Offered
11.16 Cellix
11.16.1 Business Overview
11.16.2 Products Offered
11.17 Micronit Microtechnologies
11.17.1 Business Overview
11.17.2 Products Offered
*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.
12 Appendix
12.1 Insights of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets Subscription Portal
12.4 Introducing RT: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details
List of Tables (167 Tables)
Table 1 Impact Analysis: Market Drivers
Table 2 Impact Analysis: Market Restraints
Table 3 Impact Analysis: Market Opportunities
Table 4 Impact Analysis: Market Challenges
Table 5 List of University Startups in the Microfluidics Market
Table 6 By Application, 20162023 (USD Million)
Table 7 Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 8 Market for in Vitro Diagnostics, By Country, 20162023 (USD Million)
Table 9 Market for Point-Of-Care Testing, By Country, 20162023 (USD Million)
Table 10 Market for Clinical Diagnostics, By Country, 20162023 (USD Million)
Table 11 Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 12 Market for Pharmaceutical and Life Science Research, By Country, 20162023 (USD Million)
Table 13 Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 14 Market for Lab Analytics, By Country, 20162023 (USD Million)
Table 15 Market for Proteomic Analysis, By Country, 20162023 (USD Million)
Table 16 Market for Genomic Analysis, By Country, 20162023 (USD Million)
Table 17 Market for Cell-Based Assays, By Country, 20162023 (USD Million)
Table 18 Market for Capillary Electrophoresis, By Country, 20162023 (USD Million)
Table 19 Market for Microdispensing, By Country, 20162023 (USD Million)
Table 20 Microfluidics Market for Microreaction, By Country, 20162023 (USD Million)
Table 21 Market for Drug Delivery, By Country, 20162023 (USD Million)
Table 22 Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 23 Market for Laboratory Testing, By Country, 20162023 (USD Million)
Table 24 Market for Agro Food Testing, By Country, 20162023 (USD Million)
Table 25 Market for Industrial Testing, By Country, 20162023 (USD Million)
Table 26 Market for Environmental Testing, By Country, 20162023 (USD Million)
Table 27 Microfluidics Market for High Throughput Screening, By Country, 20162023 (Usd Million)
Table 28 Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 29 Microfluidic Components Market, By Country, 20162023 (USD Million)
Table 30 Microfluidic Chips Market, By Country, 20162023 (USD Million)
Table 31 Microfluidic Sensors Market, By Country, 20162023 (USD Million)
Table 32 Micropumps Market, By Country, 20162023 (USD Million)
Table 33 Microneedles Market, By Country, 20162023 (USD Million)
Table 34 Other Microfluidic Components Market, By Country, 20162023 (USD Million)
Table 35 Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 36 Polymer-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 37 Glass-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 38 Silicon-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 39 Other Material-Based Microfluidics Market, By Country, 20162023 (USD Million)
Table 40 By Region, 20162023 (USD Million)
Table 41 North America: Market, By Country, 20162023 (USD Million)
Table 42 North America: Market, By Application, 20162023 (USD Million)
Table 43 North America: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 44 North America: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 45 North America: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 46 North America: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 47 North America: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 48 North America: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 49 US: Market, By Application, 20162023 (USD Million)
Table 50 US: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 51 US: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 52 US: Microfluidics Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 53 US: Microfluidics Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 54 US: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 55 US: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 56 Canada: Market, By Application, 20162023 (USD Million)
Table 57 Canada: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 58 Canada: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 59 Canada: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 60 Canada: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 61 Canada: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 62 Canada: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 63 Europe: Market, By Country, 20162023 (USD Million)
Table 64 Europe: Market, By Application, 20162023 (USD Million)
Table 65 Europe: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 66 Europe: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 67 Europe: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 68 Europe: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 69 Europe: Components Market, By Type, 20162023 (USD Million)
Table 70 Europe: Components Market, By Material, 20162023 (USD Million)
Table 71 Germany: Market, By Application, 20162023 (USD Million)
Table 72 Germany: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 73 Germany: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 74 Germany: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 75 Germany: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 76 Germany: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 77 Germany: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 78 France: Market, By Application, 20162023 (USD Million)
Table 79 France: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 80 France: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 81 France: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 82 France: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 83 France: Components Market, By Type, 20162023 (USD Million)
Table 84 France: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 85 UK: Market, By Application, 20162023 (USD Million)
Table 86 UK: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 87 UK: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 88 UK: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 89 UK: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 90 UK: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 91 UK: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 92 Italy: Market, By Application, 20162023 (USD Million)
Table 93 Italy: Market for in Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 94 Italy: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 95 Italy: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 96 Italy: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 97 Italy: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 98 Italy: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 99 Spain: Market, By Application, 20162023 (USD Million)
Table 100 Spain: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 101 Spain: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 102 Spain: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 103 Spain: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 104 Spain: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 105 Spain: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 106 Rest of Europe: Market, By Application, 20162023 (USD Million)
Table 107 Rest of Europe: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 108 Rest of Europe: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 109 Rest of Europe: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 110 Rest of Europe: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 111 Rest of Europe: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 112 Rest of Europe: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 113 Asia Pacific: Market, By Country, 20162023 (USD Million)
Table 114 Asia Pacific: Market, By Application, 20162023 (USD Million)
Table 115 Asia Pacific: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 116 Asia Pacific: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 117 Asia Pacific: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 118 Asia Pacific: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 119 Asia Pacific: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 120 Asia Pacific: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 121 Japan: Market, By Application, 20162023 (USD Million)
Table 122 Japan: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 123 Japan: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 124 Japan: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 125 Japan: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 126 Japan: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 127 Japan: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 128 China: Microfluidics Market, By Application, 20162023 (USD Million)
Table 129 China: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 130 China: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 131 China: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 132 China: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 133 China: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 134 China: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 135 India: Microfluidics Market, By Application, 20162023 (USD Million)
Table 136 India: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 137 India: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 138 India: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 139 India: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 140 India: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 141 India: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 142 Rest of Asia Pacific: Microfluidics Market, By Application, 20162023 (USD Million)
Table 143 Rest of Asia Pacific: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 144 Rest of Asia Pacific: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 145 Rest of Asia Pacific: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 146 Rest of APAC: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 147 Rest of APAC: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 148 Rest of APAC: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 149 Latin America: Microfluidics Market, By Application, 20162023 (USD Million)
Table 150 Latin America: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 151 Latin America: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 152 Latin America: Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 153 Latin America: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 154 Latin America: Microfluidics Components Market, By Type, 20162023 (USD Million)
Table 155 Latin America: Microfluidics Components Market, By Material, 20162023 (USD Million)
Table 156 Middle East & Africa: Microfluidics Market, By Application, 20162023 (USD Million)
Table 157 Middle East & Africa: Market for In-Vitro Diagnostics, By Type, 20162023 (USD Million)
Table 158 Middle East & Africa: Market for Pharmaceutical and Life Science Research, By Type, 20162023 (USD Million)
Table 159 Middle East & Africa: Microfluidics Market for Lab Analytics, By Type, 20162023 (USD Million)
Table 160 Middle East & Africa: Market for Laboratory Testing, By Type, 20162023 (USD Million)
Table 161 Middle East & Africa: Microfluidic Components Market, By Type, 20162023 (USD Million)
Table 162 Middle East & Africa: Microfluidic Components Market, By Material, 20162023 (USD Million)
Table 163 Product Portfolio Analysis of Major Players in the Market
Table 164 Product Launches
Table 165 Partnerships, Agreements, and Collaborations
Table 166 Acquisitions
Table 167 Expansions
List of Figures (51 Figures)
Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side)
Figure 4 Breakdown of Primary Interviews (Demand Side)
Figure 5 Data Triangulation Methodology
Figure 6 in Vitro Diagnostics Application Segment to Witness Highest Growth in the Microfluidics Market
Figure 7 Point-Of-Care Segment Accounted for the Largest Share in 2017
Figure 8 Polymer-Based MicrofluidicsThe Largest Segment of the Microfluidic Components Market, By Material
Figure 9 Microfluidic Chips to Dominate the Microfluidic Components Market, By Type
Figure 10 Geographic Analysis: Global Market, 2017
Figure 11 Rising Demand for Point-Of-Care Testing is Driving the Growth of the Global Microfluidics Market
Figure 12 Japan Accounted for the Largest Share of the Asia Pacific Microfluidic Components Market in 2017
Figure 13 US Accounted for the Largest Share of the Market in 2017
Figure 14 North America is Projected to Dominate the Market During the Forecast Period
Figure 15 High Growth Opportunity in Both Developing and Developed Markets During the Forecast Period
Figure 16 Microfluidics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Market Players Shifting Toward the Adoption of Polymers
Figure 18 Proteomics and Genomics Segments to Register the Highest CAGRs By 2023
Figure 19 in Vitro Diagnostics: Market Snapshot
Figure 20 Point-Of-Care Diagnostics: Market Snapshot
Figure 21 Proteomics: Market Snapshot
Figure 22 Genomics: Market Snapshot
Figure 23 Capillary Electrophoresis Systems: Market Snapshot
Figure 24 Value Chain Analysis
Figure 25 Market, By Application, 2018 vs 2023 (USD Million)
Figure 26 Point-Of-Care Testing Segment to Register the Highest CAGR During the Forecast Period
Figure 27 Lab Analytics Accounted for the Largest Share in the Global Market for Pharmaceutical and Life Science Research in 2017
Figure 28 Microfluidics Market for Lab Analytics, By Type, 2018 vs 2023 (USD Million)
Figure 29 Microfluidics Market for Laboratory Testing, By Type, 2018 vs 2023 (USD Million)
Figure 30 Microfluidic Chips Segment to Dominate the Microfluidic Components Market, By Type, During the Forecast Period
Figure 31 Polymer-Based Microfluidics Segment to Dominate the Microfluidic Components Market, By Material, During the Forecast Period
Figure 32 China & India are Expected to Register the Highest Growth Rates in Microfluidics Market During the Forecast Period
Figure 33 North America: Market Snapshot
Figure 34 Europe: Market Snapshot
Figure 35 Asia Pacific: Market Snapshot
Figure 36 Key Developments in the Market (2015 to 2018)
Figure 37 Growth Strategy Matrix (2015 2018)
Figure 38 Comparative Assessment of Key Players for R&D Expenditure (2017)
Figure 39 Competitive Assessment of Key Players in the Geographic Market (2017)
Figure 40 Company Snapshot: Danaher Corporation (2017)
Figure 41 Company Snapshot: Thermo Fisher Scientific (2017)
Figure 42 Perkinelmer: Company Snapshot (2017)
Figure 43 Company Snapshot: Agilent Technologies (2017)
Figure 44 Company Snapshot: Bio-Rad Laboratories (2017)
Figure 45 BD: Company Snapshot (2017)
Figure 46 Illumina: Company Snapshot (2017)
Figure 47 F. Hoffmann-La Roche Ltd.: Company Snapshot (2017)
Figure 48 Fluidigm Corporation: Company Snapshot (2017)
Figure 49 Qiagen: Company Snapshot (2016)
Figure 50 Abbott: Company Snapshot (2017)
Figure 51 Biomιrieux: Company Snapshot (2017)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Microfluidics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Microfluidics Market